Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi
Notification No. 13/2015-2020-DGFT
New Delhi, Dated: 18th June 2020
Subject: – Amendment in Export Policy of Hydroxychloroquine API and its Formulations.
S.O. 1963(E).- In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendments in the Notification No. 54 dated 25.03.2020 amending the Schedule 2 of the ITCHS Export Policy related to export of Hydroxychloroquine and its formulations, with immediate effect:
S.No. |
ITC HS Code |
Item Description |
Present Policy |
Revised Policy |
207 F |
29334900
29333990
29339900 |
Hydroxychloroquine |
Prohibited |
Free |
207 F |
30049059
30049099 |
Formulations made from Hydroxychloroquine |
Prohibited |
Free |
2 Effect of this Notification:
The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of Hydroxychloroquine API and its formulations from “Prohibited” to “Free”, with immediate effect.
(Issued from file No. 01/91/180/21 /AM20/EC/E-21154)
(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary to the Government of India
Note: The principal notification No. 36/2015-2020, dated the 17th January, 2017 was published in the Gazette of India, Extraordinary vide number S.O. 172 (E), dated the 17th January, 2017 and amended vide notification No. 27/2015-2020, dated the 21st August, 2018 was published in Gazette of India Extraordinary vide number S.O. 4054(E) dated the 21st August 2018
|